US 11389432
Methods of treating cancer comprising administration of a glucocorticoid receptor modulator and a cancer chemotherapy agent
granted A61KA61K31/337A61K31/437
Quick answer
US patent 11389432 (Methods of treating cancer comprising administration of a glucocorticoid receptor modulator and a cancer chemotherapy agent) held by Corcept Therapeutics Incorporated expires Mon Jul 14 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Corcept Therapeutics Incorporated
- Grant date
- Tue Jul 19 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 14 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K31/337, A61K31/437, A61K31/573, A61P